Microsoft-owned AI company Nuance is leveraging GPT-4 to power new software designed to ease the burden of clinical documentation for physicians.
Nuance, acquired last year by Microsoft for $19.7 billion, sells medical applications that combine voice, artificial intelligence and cloud technologies, and its product Dragon Medical has 550,000 users.
The new application, Dragon Ambient eXperience (DAX) Express, aims to extend Nuance’s capabilities in capturing, analyzing and distilling the contents of physician-patient medical encounters.
DAX Express creates draft clinical notes from an encounter. After each in-person or telehealth visit, the draft will be available for clinical review and completion. The application is integrated into Azure, Microsoft’s cloud platform.
The new application is designed to increase physician efficiency and reduce burnout and fatigue from completing clinical notes, an often time-consuming task.
The application will be showcased at the HIMSS Global Health Conference in April and will be available for preview this summer, according to an announcement Monday.
GPT-4 is the latest large language model from OpenAI, which has a deep partnership with Microsoft. GPT and other AI models have a potential wide range of healthcare use cases including as tools for medical diagnosis.
Components of Nuance’s applications have roots in Seattle digital health startup Saykara, which built a voice assistant that documented doctor-patient encounters and was acquired by Nuance in 2021. Saykara CEO and founder Harjinder Sandhu is vice president, research and development, at Nuance.
